Cofactoring and dimerization of proteinase-activated receptors

Pharmacological Reviews

Volumn 65, Issue 4, 2013, Pages 1198-1213

  Lin, Huilan ^a   Liu, Allen P ^c   Smith, Thomas H ^b   Trejo, JoAnn ^a  

^a San Diego   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; BETA ARRESTIN; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CXCR4; G PROTEIN COUPLED RECEPTOR; HETERODIMER; HIRULOG; HOMODIMER; LIGAND; MELATONIN 2 RECEPTOR; PROTEINASE ACTIVATED RECEPTOR; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; PROTEINASE ACTIVATED RECEPTOR 3; PROTEINASE ACTIVATED RECEPTOR 4; THROMBIN; THROMBIN RECEPTOR; VORAPAXAR;

ANTIGEN BINDING; BINDING SITE; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; BIOSYNTHESIS; BLEACHING; CANCER GROWTH; CELL PROTECTION; CELL SURFACE; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONFORMATIONAL TRANSITION; CROSS REACTION; DESENSITIZATION; DIMERIZATION; ENDOPLASMIC RETICULUM; ENDOTHELIUM CELL; FIBROBLAST; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; IMMUNOPRECIPITATION; INTRACELLULAR SIGNALING; INTRACELLULAR SPACE; MOLECULAR WEIGHT; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; REVIEW; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE RELEASE REACTION; THROMBOCYTE SHAPE; TRANSACTIVATION; X RAY CRYSTALLOGRAPHY;

EID: 84888178878     PISSN: 00316997     EISSN: 15210081     Source Type: Journal    
DOI: 10.1124/pr.111.004747     Document Type: Review

References (94)

1. Achour L, Labbé-Jullié C, Scott MG, and Marullo S (2008) An escort for GPCRs: implications for regulation of receptor density at the cell surface. Trends Pharmacol Sci 29:528-535.
2. Adams MN, Pagel CN, Mackie EJ, and Hooper JD (2012) Evaluation of antibodies directed against human protease-activated receptor-2. Naunyn Schmiedebergs Arch Pharmacol 385:861-873.
3. Albizu L, Cottet M, Kralikova M, Stoev S, Seyer R, Brabet I, Roux T, Bazin H, Bourrier E, and Lamarque L, et al. (2010) Time-resolved FRET between GPCR ligands reveals oligomers in native tissues. Nat Chem Biol 6:587-594.
4. Antoniak S, Owens AP 3rd, Baunacke M, Williams JC, Lee RD, Weithäuser A, Sheridan PA, Malz R, Luyendyk JP, and Esserman DA, et al. (2013) PAR-1 contributes to the innate immune response during viral infection. J Clin Invest 123: 1310-1322.
5. Arachiche A, de la Fuente M, and Nieman MT (2013) Calcium mobilization and protein kinase C activation downstream of protease activated receptor 4 (PAR4) is negatively regulated by PAR3 in mouse platelets. PLoS ONE 8:e55740.
6. Arora P, Ricks TK, and Trejo J (2007) Protease-activated receptor signalling, endocytic sorting and dysregulation in cancer. J Cell Sci 120:921-928.
7. Austin KM, Covic L, and Kuliopulos A (2013) Matrix metalloproteases and PAR1 activation. Blood 121:431-439.
8. Ayoub MA, Couturier C, Lucas-Meunier E, Angers S, Fossier P, Bouvier M, and Jockers R (2002) Monitoring of ligand-independent dimerization and ligandinduced conformational changes of melatonin receptors in living cells by bioluminescence resonance energy transfer. J Biol Chem 277:21522-21528.
9. Bah A, Chen Z, Bush-Pelc LA, Mathews FS, and Di Cera E (2007) Crystal structures of murine thrombin in complex with the extracellular fragments of murine protease-activated receptors PAR3 and PAR4. Proc Natl Acad Sci USA 104: 11603-11608.
10. Bayburt TH, Vishnivetskiy SA, McLean MA, Morizumi T, Huang CC, Tesmer JJ, Ernst OP, Sligar SG, and Gurevich VV (2011) Monomeric rhodopsin is sufficient for normal rhodopsin kinase (GRK1) phosphorylation and arrestin-1 binding. J Biol Chem 286:1420-1428.
11. Blackhart BD, Emilsson K, Nguyen D, Teng W, Martelli AJ, Nystedt S, Sundelin J, and Scarborough RM (1996) Ligand cross-reactivity within the protease-activated receptor family. J Biol Chem 271:16466-16471.
12. Bouvier M (2001) Oligomerization of G-protein-coupled transmitter receptors. Nat Rev Neurosci 2:274-286.
13. Camerer E, Barker A, Duong DN, Ganesan R, Kataoka H, Cornelissen I, Darragh MR, Hussain A, Zheng YW, and Srinivasan Y, et al. (2010) Local protease signaling contributes to neural tube closure in the mouse embryo. Dev Cell 18:25-38.
14. Canals M, Burgueño J, Marcellino D, Cabello N, Canela EI, Mallol J, Agnati L, Ferré S, Bouvier M, and Fuxe K, et al. (2004) Homodimerization of adenosine A2A receptors: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer. J Neurochem 88:726-734.
15. Canals M, Marcellino D, Fanelli F, Ciruela F, de Benedetti P, Goldberg SR, Neve K, Fuxe K, Agnati LF, and Woods AS, et al. (2003) Adenosine A2A-dopamine D2 receptor-receptor heteromerization: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer. J Biol Chem 278:46741-46749.
16. Chen B, Dores MR, Grimsey N, Canto I, Barker BL, and Trejo J (2011) Adaptor protein complex-2 (AP-2) and epsin-1 mediate protease-activated receptor-1 internalization via phosphorylation-and ubiquitination-dependent sorting signals. J Biol Chem 286:40760-40770.
17. Chen CH, Paing MM, and Trejo J (2004) Termination of protease-activated receptor-1 signaling by b-arrestins is independent of receptor phosphorylation. J Biol Chem 279:10020-10031.
18. Chen J, Ishii M, Wang L, Ishii K, and Coughlin SR (1994) Thrombin receptor activation. Confirmation of the intramolecular tethered liganding hypothesis and discovery of an alternative intermolecular liganding mode. J Biol Chem 269: 16041-16045.
19. Coughlin SR (1994) Protease-activated receptors start a family. Proc Natl Acad Sci USA 91:9200-9202.
20. Coughlin SR (1999) How the protease thrombin talks to cells. Proc Natl Acad Sci USA 96:11023-11027.
21. Coughlin SR (2005) Protease-activated receptors in hemostasis, thrombosis and vascular biology. J Thromb Haemost 3:1800-1814.
22. Coulon V, Audet M, Homburger V, Bockaert J, Fagni L, Bouvier M, and Perroy J (2008) Subcellular imaging of dynamic protein interactions by bioluminescence resonance energy transfer. Biophys J 94:1001-1009.
23. Covic L, Gresser AL, and Kuliopulos A (2000) Biphasic kinetics of activation and signaling for PAR1 and PAR4 thrombin receptors in platelets. Biochemistry 39: 5458-5467.
24. Cunningham MR, McIntosh KA, Pediani JD, Robben J, Cooke AE, Nilsson M, Gould GW, Mundell S, Milligan G, and Plevin R (2012) Novel role for proteinase-activated receptor 2 (PAR2) in membrane trafficking of proteinase-activated receptor 4 (PAR4). J Biol Chem 287:16656-16669.
25. de la Fuente M, Noble DN, Verma S, and Nieman MT (2012) Mapping human protease-activated receptor 4 (PAR4) homodimer interface to transmembrane helix 4. J Biol Chem 287:10414-10423.
26. De Fea KA, Zalevsky J, Thoma MS, Déry O, Mullins RD, and Bunnett NW (2000) b-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2. J Cell Biol 148:1267-1281.
27. Dorsch S, Klotz KN, Engelhardt S, Lohse MJ, and Bünemann M (2009) Analysis of receptor oligomerization by FRAP microscopy. Nat Methods 6:225-230.
28. Ejendal KF, Conley JM, Hu CD, and Watts VJ (2013) Bimolecular fluorescence complementation analysis of G protein-coupled receptor dimerization in living cells. Methods Enzymol 521:259-279.
29. Feistritzer C, Lenta R, and Riewald M (2005) Protease-activated receptors-1 and-2 can mediate endothelial barrier protection: role in factor Xa signaling. J Thromb Haemost 3:2798-2805.
30. Fonseca JM and Lambert NA (2009) Instability of a class a G protein-coupled receptor oligomer interface. Mol Pharmacol 75:1296-1299.
31. Griffin CT, Srinivasan Y, Zheng Y-W, Huang W, and Coughlin SR (2001) A role for thrombin receptor signaling in endothelial cells during embryonic development. Science 293:1666-1670.
32. Hamdan FF, Percherancier Y, Breton B, and Bouvier M (2006) Monitoring proteinprotein interactions in living cells by bioluminescence resonance energy transfer (BRET). Curr Protoc Neurosci Chapter 5:Unit 5.23.
33. Holinstat M, Voss B, Bilodeau ML, McLaughlin JN, Cleator J, and Hamm HE (2006) PAR4, but not PAR1, signals human platelet aggregation via Ca2+ mobilization and synergistic P2Y12 receptor activation. J Biol Chem 281:26665-26674.
34. Hotchkiss RS and Karl IE (2003) The pathophysiology and treatment of sepsis. N Engl J Med 348:138-150.
35. Huang J, Chen S, Zhang JJ, and Huang XY (2013) Crystal structure of oligomeric b1-adrenergic G protein-coupled receptors in ligand-free basal state. Nat Struct Mol Biol 20:419-425.
36. Ishihara H, Connolly AJ, Zeng D, Kahn ML, Zheng YW, Timmons C, Tram T, and Coughlin SR (1997) Protease-activated receptor 3 is a second thrombin receptor in humans. Nature 386:502-506.
37. Ishihara H, Zeng D, Connolly AJ, Tam C, and Coughlin SR (1998) Antibodies to protease-activated receptor 3 inhibit activation of mouse platelets by thrombin. Blood 91:4152-4157.
38. Jacques SL and Kuliopulos A (2003) Protease-activated receptor-4 uses dual prolines and an anionic retention motif for thrombin recognition and cleavage. Biochem J 376:733-740.
39. Jacques SL, LeMasurier M, Sheridan PJ, Seeley SK, and Kuliopulos A (2000) Substrate-assisted catalysis of the PAR1 thrombin receptor. Enhancement of macromolecular association and cleavage. J Biol Chem 275:40671-40678.
40. Kahn ML, Nakanishi-Matsui M, Shapiro MJ, Ishihara H, and Coughlin SR (1999) Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J Clin Invest 103:879-887.
41. Kahn ML, Zheng YW, Huang W, Bigornia V, Zeng D, Moff S, Farese RV Jr, Tam C, and Coughlin SR (1998) A dual thrombin receptor system for platelet activation. Nature 394:690-694.
42. Kaneider NC, Leger AJ, Agarwal A, Nguyen N, Perides G, Derian C, Covic L, and Kuliopulos A (2007) 'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage. Nat Immunol 8:1303-1312.
43. Komarova YA, Mehta D, and Malik AB (2007) Dual regulation of endothelial junctional permeability. Sci STKE 2007:re8.
44. Leger AJ, Jacques SL, Badar J, Kaneider NC, Derian CK, Andrade-Gordon P, Covic L, and Kuliopulos A (2006) Blocking the protease-activated receptor 1-4 heterodimer in platelet-mediated thrombosis. Circulation 113:1244-1254.
45. Lidington EA, Steinberg R, Kinderlerer AR, Landis RC, Ohba M, Samarel A, Haskard DO, and Mason JC (2005) A role for proteinase-activated receptor 2 and PKC-epsilon in thrombin-mediated induction of decay-accelerating factor on human endothelial cells. Am J Physiol Cell Physiol 289:C1437-C1447.
46. Lin H and Trejo J (2013) Transactivation of the PAR1-PAR2 heterodimer by thrombin elicits b-arrestin-mediated endosomal signaling. J Biol Chem 288: 11203-11215.
47. Lohse MJ, Nuber S, and Hoffmann C (2012) Fluorescence/bioluminescence resonance energy transfer techniques to study G-protein-coupled receptor activation and signaling. Pharmacol Rev 64:299-336.
48. Madhusudhan T, Wang H, Straub BK, Gröne E, Zhou Q, Shahzad K, Müller-Krebs S, Schwenger V, Gerlitz B, and Grinnell BW, et al. (2012) Cytoprotective signaling by activated protein C requires protease-activated receptor-3 in podocytes. Blood 119: 874-883.
49. Manglik A, Kruse AC, Kobilka TS, Thian FS, Mathiesen JM, Sunahara RK, Pardo L, Weis WI, Kobilka BK, and Granier S (2012) Crystal structure of the m-opioid receptor bound to a morphinan antagonist. Nature 485:321-326.
50. Maurel D, Comps-Agrar L, Brock C, Rives ML, Bourrier E, Ayoub MA, Bazin H, Tinel N, Durroux T, and Prézeau L, et al. (2008) Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies: application to GPCR oligomerization. Nat Methods 5:561-567.
51. McLaughlin JN, Patterson MM, and Malik AB (2007) Protease-activated receptor-3 (PAR3) regulates PAR1 signaling by receptor dimerization. Proc Natl Acad Sci USA 104:5662-5667.
52. Moers A, Nieswandt B, Massberg S, Wettschureck N, Grüner S, Konrad I, Schulte V, Aktas B, Gratacap MP, and Simon MI, et al. (2003) G13 is an essential mediator of platelet activation in hemostasis and thrombosis. Nat Med 9:1418-1422.
53. Molino M, Barnathan ES, Numerof R, Clark J, Dreyer M, Cumashi A, Hoxie JA, Schechter N, Woolkalis M, and Brass LF (1997) Interactions of mast cell tryptase with thrombin receptors and PAR-2. J Biol Chem 272:4043-4049.
54. Mosnier LO, Sinha RK, Burnier L, Bouwens EA, and Griffin JH (2012) Biased agonism of protease-activated receptor 1 by activated protein C caused by noncanonical cleavage at Arg46. Blood 120:5237-5246.
55. Mosnier LO, Zlokovic BV, and Griffin JH (2007) The cytoprotective protein C pathway. Blood 109:3161-3172.
56. Nakanishi-Matsui M, Zheng Y-W, Sulciner DJ, Weiss EJ, Ludeman MJ, and Coughlin SR (2000) PAR3 is a cofactor for PAR4 activation by thrombin. Nature 404:609-613.
57. Nystedt S, Emilsson K, Wahlestedt C, and Sundelin J (1994) Molecular cloning of a potential proteinase activated receptor. Proc Natl Acad Sci USA 91: 9208-9212.
58. Nystedt S, Ramakrishnan V, and Sundelin J (1996) The proteinase-activated receptor 2 is induced by inflammatory mediators in human endothelial cells. Comparison with the thrombin receptor. J Biol Chem 271:14910-14915.
59. O'Brien PJ, Molino M, Kahn M, and Brass LF (2001) Protease activated receptors: theme and variations. Oncogene 20:1570-1581.
60. O'Brien PJ, Prevost N, Molino M, Hollinger MK, Woolkalis MJ, Woulfe DS, and Brass LF (2000) Thrombin responses in human endothelial cells. Contributions from receptors other than PAR1 include the transactivation of PAR2 by thrombincleaved PAR1. J Biol Chem 275:13502-13509.
61. Offermanns S, Toombs CF, Hu YH, and Simon MI (1997) Defective platelet activation in G alpha(q)-deficient mice. Nature 389:183-186.
62. Oldham WM and Hamm HE (2008) Heterotrimeric G protein activation by G-proteincoupled receptors. Nat Rev Mol Cell Biol 9:60-71.
63. Paing MM, Johnston CA, Siderovski DP, and Trejo J (2006) Clathrin adaptor AP2 regulates thrombin receptor constitutive internalization and endothelial cell resensitization. Mol Cell Biol 26:3231-3242.
64. Percherancier Y, Berchiche YA, Slight I, Volkmer-Engert R, Tamamura H, Fujii N, Bouvier M, and Heveker N (2005) Bioluminescence resonance energy transfer reveals ligand-induced conformational changes in CXCR4 homo-and heterodimers. J Biol Chem 280:9895-9903.
65. Perroy J, Pontier S, Charest PG, Aubry M, and Bouvier M (2004) Real-time monitoring of ubiquitination in living cells by BRET. Nat Methods 1:203-208.
66. Pfeiffer M, Kirscht S, Stumm R, Koch T, Wu D, Laugsch M, Schröder H, Höllt V, and Schulz S (2003) Heterodimerization of substance P and mu-opioid receptors regulates receptor trafficking and resensitization. J Biol Chem 278:51630-51637.
67. Pfleger KD, Dromey JR, Dalrymple MB, Lim EM, Thomas WG, and Eidne KA (2006) Extended bioluminescence resonance energy transfer (eBRET) for monitoring prolonged protein-protein interactions in live cells. Cell Signal 18:1664-1670.
68. Pin JP, Galvez T, and Prézeau L (2003) Evolution, structure, and activation mechanism of family 3/C G-protein-coupled receptors. Pharmacol Ther 98:325-354.
69. Ramachandran R, Noorbakhsh F, Defea K, and Hollenberg MD (2012) Targeting proteinase-activated receptors: therapeutic potential and challenges. Nat Rev Drug Discov 11:69-86.
70. Ricks TK and Trejo J (2009) Phosphorylation of protease-activated receptor-2 differentially regulates desensitization and internalization. J Biol Chem 284: 34444-34457.
71. Rozenfeld R and Devi LA (2011) Exploring a role for heteromerization in GPCR signalling specificity. Biochem J 433:11-18.
72. Russo A, Soh UJ, Paing MM, Arora P, and Trejo J (2009) Caveolae are required for protease-selective signaling by protease-activated receptor-1. Proc Natl Acad Sci USA 106:6393-6397.
73. Rydel TJ, Ravichandran KG, Tulinsky A, Bode W, Huber R, Roitsch C, and Fenton JW 2nd (1990) The structure of a complex of recombinant hirudin and human alpha-thrombin. Science 249:277-280.
74. Salahpour A, Angers S, Mercier JF, Lagacé M, Marullo S, and Bouvier M (2004) Homodimerization of the beta2-adrenergic receptor as a prerequisite for cell surface targeting. J Biol Chem 279:33390-33397.
75. Salahpour A, Espinoza S, Masri B, Lam V, Barak LS, and Gainetdinov RR (2012) BRET biosensors to study GPCR biology, pharmacology, and signal transduction. Front Endocrinol (Lausanne) 3:105.
76. Sambrano GR, Weiss EJ, Zheng YW, Huang W, and Coughlin SR (2001) Role of thrombin signalling in platelets in haemostasis and thrombosis. Nature 413:74-78.
77. Scarborough RM, Naughton MA, Teng W, Hung DT, Rose J, Vu TK, Wheaton VI, Turck CW, and Coughlin SR (1992) Tethered ligand agonist peptides. Structural requirements for thrombin receptor activation reveal mechanism of proteolytic unmasking of agonist function. J Biol Chem 267:13146-13149.
78. Seeley S, Covic L, Jacques SL, Sudmeier J, Baleja JD, and Kuliopulos A (2003) Structural basis for thrombin activation of a protease-activated receptor: inhibition of intramolecular liganding. Chem Biol 10:1033-1041.
79. Sevigny LM, Zhang P, Bohm A, Lazarides K, Perides G, Covic L, and Kuliopulos A (2011) Interdicting protease-activated receptor-2-driven inflammation with cellpenetrating pepducins. Proc Natl Acad Sci USA 108:8491-8496.
80. Shapiro MJ, Trejo J, Zeng D, and Coughlin SR (1996) Role of the thrombin receptor's cytoplasmic tail in intracellular trafficking. Distinct determinants for agonisttriggered versus tonic internalization and intracellular localization. J Biol Chem 271:32874-32880.
81. Shapiro MJ, Weiss EJ, Faruqi TR, and Coughlin SR (2000) Protease-activated receptors 1 and 4 are shut off with distinct kinetics after activation by thrombin. J Biol Chem 275:25216-25221.
82. Shi X, Gangadharan B, Brass LF, Ruf W, and Mueller BM (2004) Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis. Mol Cancer Res 2:395-402.
83. Soh UJ, Dores MR, Chen B, and Trejo J (2010) Signal transduction by proteaseactivated receptors. Br J Pharmacol 160:191-203.
84. Soh UJ and Trejo J (2011) Activated protein C promotes protease-activated receptor-1 cytoprotective signaling through b-arrestin and dishevelled-2 scaffolds. Proc Natl Acad Sci USA 108:E1372-E1380.
85. Soto AG and Trejo J (2010) N-Linked glycosylation of protease-activated receptor-1 second extracellular loop: a critical determinant for ligand-induced receptor activation and internalization. J Biol Chem 285:18781-18793.
86. Stalheim L, Ding Y, Gullapalli A, Paing MM, Wolfe BL, Morris DR, and Trejo J (2005) Multiple independent functions of arrestins in the regulation of proteaseactivated receptor-2 signaling and trafficking. Mol Pharmacol 67:78-87.
87. Vouret-Craviari V, Grall D, Chambard JC, Rasmussen UB, Pouysségur J, and Van Obberghen-Schilling E (1995) Post-translational and activation-dependent modifications of the G protein-coupled thrombin receptor. J Biol Chem 270:8367-8372.
88. Vu TK, Hung DT, Wheaton VI, and Coughlin SR (1991a) Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64:1057-1068.
89. Vu TK, Wheaton VI, Hung DT, Charo I, and Coughlin SR (1991b) Domains specifying thrombin-receptor interaction. Nature 353:674-677.
90. Whorton MR, Bokoch MP, Rasmussen SG, Huang B, Zare RN, Kobilka B, and Sunahara RK (2007) A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein. Proc Natl Acad Sci USA 104:7682-7687.
91. Wu B, Chien EY, Mol CD, Fenalti G, Liu W, Katritch V, Abagyan R, Brooun A, Wells P, and Bi FC, et al. (2010) Structures of the CXCR4 chemokine GPCR with smallmolecule and cyclic peptide antagonists. Science 330:1066-1071.
92. Wu H, Wacker D, Mileni M, Katritch V, Han GW, Vardy E, Liu W, Thompson AA, Huang XP, and Carroll FI, et al. (2012) Structure of the human k-opioid receptor in complex with JDTic. Nature 485:327-332.
93. Xu WF, Andersen H, Whitmore TE, Presnell SR, Yee DP, Ching A, Gilbert T, Davie EW, and Foster DC (1998) Cloning and characterization of human proteaseactivated receptor 4. Proc Natl Acad Sci USA 95:6642-6646.
94. Zhang C, Srinivasan Y, Arlow DH, Fung JJ, Palmer D, Zheng Y, Green HF, Pandey A, Dror RO, and Shaw DE, et al. (2012) High-resolution crystal structure of human protease-activated receptor 1. Nature 492:387-392.